The COVID-19 pandemic has presented a unique challenge, testing the healthcare system at a global level. The primary objective of healthcare facilities in these dire circumstances has been to treat the respiratory failure associated with viral pneumonia. However, a growing amount of literature has started to emphasise the importance of a well-rounded approach and has shed light on the various other manifestations of the disease. Amongst these significant manifestations is the risk of thrombotic events and the need for appropriate thromboprophylaxis in hospitalised patients in order to reduce patient morbidity and mortality. However, in developing nations like Pakistan, where there has been striking depravity of basic healthcare provisions at government facilities, the necessity of thromboprophylaxis is currently being overlooked.
COVID-19, coronavirus, thromboprophylaxis, heparin, anticoagulation
Access all of the content
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!